November 09, 2009
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Lorene Janowski, Occupational Therapist
Tracy Klein
This study proposes to review three cases of patients who presented with upper extremity issues, post hemispherectomy, to determine similarities between the patients and the outcomes of subsequent upper extremity surgical procedures. The patients have already been determined via retrospective chart review.
Inclusion:
1. Surgically underwent hemispherectomy
2. Present with upper extremity issues
3. Surgically treated by the principle investigator for upper extremity issue
Exclusion:
1. Not treated by PI for upper extremity issue post-hemispherectomy.
Tracy Klein
KleinT@hss.edu
212.774.2727